BEN vs INM · P/E 36, rev $8.77B vs rev $4.9M
Franklin Resources Inc (BEN) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. INM currently screens at market cap $5.2M.
Not investment advice. Open the BEN and INM stock pages for the full models.
Not investment advice.